These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 9430878

  • 1. Castleman's disease with renal amyloidosis and nephrotic syndrome.
    Arinsoy T, Yilmaz M, Ataoğlu O, Bali M, Sindel S.
    Nephrol Dial Transplant; 1997 Dec; 12(12):2713-6. PubMed ID: 9430878
    [No Abstract] [Full Text] [Related]

  • 2. Regression of nephrotic syndrome with colchicine therapy secondary to amyloidosis with associated Castleman's disease.
    Paydas S, Gonlusen G, Sagliker Y.
    Nephron; 1995 Dec; 71(4):463-4. PubMed ID: 8587630
    [No Abstract] [Full Text] [Related]

  • 3. Castleman's disease with nephrotic syndrome, amyloidosis and autoimmune manifestations.
    Curioni S, D'Amico M, Quartagno R, Martino S, Dell'Antonio G, Cusi D.
    Nephrol Dial Transplant; 2001 Jul; 16(7):1475-8. PubMed ID: 11427644
    [No Abstract] [Full Text] [Related]

  • 4. Remission of nephrotic syndrome after removal of localized Castleman's disease.
    Keven K, Nergizoğlu G, Ateş K, Erekul S, Orhan D, Ertürk S, Tulunay O, Karatan O, Ertuğ AE.
    Am J Kidney Dis; 2000 Jun; 35(6):1207-11. PubMed ID: 10845836
    [Abstract] [Full Text] [Related]

  • 5. [Highly thrombogenic forms of Behçet's disease associated with Castleman's disease and renal amyloidosis].
    Belgnaoui F, Raki S, Douira L, Benabdellah L, Rimani M, Labraïmi A, Aouni M, Senouci K, Hassam B.
    Ann Dermatol Venereol; 2006 Mar; 133(3):278-80. PubMed ID: 16800185
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Nephrotic syndrome associated with angiofollicular lymph node hyperplasia, and subsequent amyloidosis.
    Chan KW, Lo WK, Cheng IK.
    Pathology; 1992 Jul; 24(3):229-30. PubMed ID: 1437301
    [No Abstract] [Full Text] [Related]

  • 8. [Nephrotic Syndrome Caused by AA Amyloidosis Secondary to Unicentric Castleman's Disease:Report of One Case].
    You RL, Wen YB, Wang J, Ma J, Chen LM, Li XM.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Jun; 44(3):540-544. PubMed ID: 35791957
    [Abstract] [Full Text] [Related]

  • 9. Secondary amyloidosis associated with Castleman's disease.
    Tanaka K, Horita M, Shibayama H, Seike M, Itoh Y, Hamaguchi K, Sato Y, Sakata T, Ishida T.
    Intern Med; 1995 Feb; 34(2):122-6. PubMed ID: 7727877
    [Abstract] [Full Text] [Related]

  • 10. End-stage renal failure from renal amyloidosis of the AA type associated with giant lymph node hyperplasia (Castleman's disease).
    Montoli A, Minola E, Stabile F, Grillo C, Radaelli L, Spanti D, Luccarelli E, Spata C, Minetti L.
    Am J Nephrol; 1995 Feb; 15(2):142-6. PubMed ID: 7733151
    [Abstract] [Full Text] [Related]

  • 11. Pregnancy and nephrotic syndrome due to renal amyloidosis.
    Feitelson PJ, Ortiz R, Lindheimer MD.
    Am J Obstet Gynecol; 1971 Sep 15; 111(2):306-7. PubMed ID: 5098601
    [No Abstract] [Full Text] [Related]

  • 12. A clinico-pathological study of renal amyloidosis in northern India.
    Vaishnava H, Gulati PD, Aurora AL.
    J Assoc Physicians India; 1969 Nov 15; 17(11):641-50. PubMed ID: 5356699
    [No Abstract] [Full Text] [Related]

  • 13. Amyloidosis in chronic heroin addicts with the nephrotic syndrome.
    Scholes J, Derosena R, Appel GB, Jao W, Boyd MT, Pirani CL.
    Ann Intern Med; 1979 Jul 15; 91(1):26-9. PubMed ID: 464449
    [Abstract] [Full Text] [Related]

  • 14. Multicentric Castleman disease with secondary AA renal amyloidosis, nephrotic syndrome and chronic renal failure, remission after high-dose melphalan and autologous stem cell transplantation.
    Ogita M, Hoshino J, Sogawa Y, Sawa N, Katori H, Takemoto F, Ubara Y, Hara S, Miyakoshi S, Takaichi K.
    Clin Nephrol; 2007 Sep 15; 68(3):171-6. PubMed ID: 17915620
    [Abstract] [Full Text] [Related]

  • 15. Grand rounds--Hammersmith Hospital. Reactive (AA) systemic amyloidosis. A cause of refractory nephrotic syndrome.
    BMJ; 1996 Apr 27; 312(7038):1087-9. PubMed ID: 8616421
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Castleman disease and renal amyloidosis.
    Kazes I, Deray G, Jacobs C.
    Ann Intern Med; 1995 Mar 01; 122(5):395-6. PubMed ID: 7847660
    [No Abstract] [Full Text] [Related]

  • 18. Remission of nephrotic syndrome after thalidomide therapy in a patient with Castleman's disease.
    Menegato MA, Canelles MF, Tonutti E, Pizzolitto S.
    Clin Nephrol; 2004 May 01; 61(5):352-6. PubMed ID: 15182131
    [Abstract] [Full Text] [Related]

  • 19. Secondary (AA) amyloidosis associated with Castleman's disease. Report of two cases and review of the literature.
    Ordi J, Grau JM, Junqué A, Nomdedeu B, Palacin A, Cardesa A.
    Am J Clin Pathol; 1993 Oct 01; 100(4):394-7. PubMed ID: 8213634
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.